Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

Completed · Not applicable

Conditions studied: Dysphagia

In brief

The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.

Key facts

Study ID

NCT01873573

Run by

H. Lee Moffitt Cancer Center and Research Institute

People needed

10

Starts

2013-07-18

Expected to finish

2017-10-16

Last updated by the study team

2017-10-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who present for EGD with dilation for dysphagia symptoms thought secondary to either radiation-induced stricture or anastomotic stricture based on history

You may not qualify if…

• Inability to consent for the procedure
• Known coagulopathy [International Normalized Ratio (INR) >1.5, Platelets <75 K]
• Endoscopic finding of a stricture that is not caused by either radiation or anastomotic narrowing
• Nasopharyngeal strictures

Where it is running

• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.